ACUTE MYELOBLASTIC LEUKEMIA DEVELOPING AFTER THE TREATMENT FOR MALIGNANT NEOPLASM OR APLASTIC ANEMIA ACQUIRED IN CHILDHOOD
https://doi.org/10.51523/2708-6011.2011-8-2s-27
Abstract
The article presents 8 cases of secondary acute myeloblastic leukemia in patients, undergoing the treatment for a malignant neoplasm or anplastic anemia acquired in childhood and 40 cases of de novo acute myeloblastic leukemia of the high risk group. The clinical laboratory characteristics, therapy and survival rate of secondary acute myeloblastic leukemia and de novo acute myeloblastic leukemia have been discussed in the article with the account of the literary up-to-date data.
About the Authors
I. P. Romashevskaya
Republican Research Centre for Pediatric Oncology and Hematology
Belarus
Belarus
N. N. Savva
Republican Research Centre for Pediatric Oncology and Hematology
Belarus
Belarus
N. P. Litvinko
Republican Research Centre for Radiation Medicine and Human Ecology
Belarus
Belarus
O. V. Aleinikova
Republican Research Centre for Radiation Medicine and Human Ecology
Belarus
Belarus
References
1. БИБЛИОГРАФИЧЕСКИЙ СПИСОК
2. The incidence of secondary leukemias / G. Leone [et al.] // Haematologica. - 1999. - Vol. 84. - P. 937-945.
3. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation / D. Barnard [et al.] // Blood. - 2002. - Vol. 100. - P. 427-434.
4. Therapy-related leukemia and myelodysplasia: susceptibility and incidence / G. Leone [et al.] // Haematologica. - 2007. - Vol. 92(10). - P. 1389-1398.
5. Acute myeloid leukemia in patients previously diagnosed with breast cancer: еxperience of the GIMEMA group / L. Pagano [et al.] // Annals of oncology. - 2001. - Vol. 12. - P. 203-207.
6. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia / C. H. Pui [et al.] // J. Clin. Oncol. - 2005. - Vol. 23. - P. 7936-7941.
7. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1974-2001 and on 5098 unselected cases reported in the literature 1974-2001 / N. Mauritzson [et al.] // Leukemia. - 2002. - Vol. 16. - P. 2366-2378.
8. Pedersen-Bjergaard, J. The balanced and unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation / J. Pedersen-Bjergaard, J. D. Rowley // Blood. - 1994. - Vol. 83. - P. 2780-2786.
9. Pedersen-Bjergaard, J. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II / J. Pedersen-Bjergaard, P. Phillip // Blood. - 1991. - Vol. 78. - P. 1147-1148.
10. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting at DNA-topoisomerase II / H. J. Gilr [et al.] // Blood. - 1993. - Vol. 82. - P. 3705-3711.
11. Pedersen-Bjergaard, J. Two different classes of therapy-related and de novo acute myeloid leukemia? / J. Pedersen-Bjergaard, P. Philip // Cancer Genet. Cytogenet. - 1991. - Vol. 55. - P. 119-124.
12. Risk factors for evolutions of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children / S. Kojima [et al.] // Blood. - 2002. - Vol. 100. - P. 786-790.
13. Genetics of therapy-related myelodysplasia and acute myeloid leukemia / J. Pedersen-Bjergaard [et al.] // Leukemia. - 2008. - Vol. 22. - P. 240-248.
14. Secondary acute myeloid leukemia: results of conventional treatments: еxperience of GIMEMA trials / L. Pagano [et al.] // Annals of oncology. - 2005. - Vol. 16 (2). - P. 228-233.
15. Toxicity and outcome of children with treatment related acute myeloid leukemia / U. Tabori [et al.] // Pediatr Blood Cancer. - 2008. - Vol. 50. - P. 17-23.
16. Rowe, J. Therapy of secondary leukemia / J. Rowe [et al.] // Leukemia. - 2002. - Vol. 16. - P. 748-750.
17. Prognosis in therapy-related acute myeloid leukemia and impact of karyotype / W. Kern [et al.] // J. Clin. Oncol. - 2004. - Vol. 22. - P. 2510-2511.
Review
For citations:
Romashevskaya I.P., Savva N.N., Litvinko N.P., Aleinikova O.V. ACUTE MYELOBLASTIC LEUKEMIA DEVELOPING AFTER THE TREATMENT FOR MALIGNANT NEOPLASM OR APLASTIC ANEMIA ACQUIRED IN CHILDHOOD. Health and Ecology Issues. 2011;(2S):79-81. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-2s-27
Views: 251
Email this article 